With one in five youths struggling with obesity, evidence-based guidance on the use of obesity pharmacotherapy for adolescents is the need of the hour claim researchers. Weight loss medications could be an effective way to reduce adolescent obesity that does not improve with other measures, reveals a report published in the journal Obesity.
"There is an emerging population of adolescents 'stuck' in between lifestyle modification therapy and bariatric surgery for which obesity pharmacotherapy may be helpful," writes Gitanjali Srivastava, MD, corresponding author. Caroline Apovian, MD, of the Boston University School of Medicine and director of the Nutrition and Weight Management Research Program at BMC, is senior author.
Childhood Obesity
Childhood obesity is one of the most serious health challenges in the developing countries and needs to be understood and tackled effectively.
Advertisement
‘Pediatric obesity is linked to an increased risk of chronic diseases in later life. Combating obesity through medications is efficient than bariatric surgery or lifestyle modification.’
Tweet it Now
In the manuscript, the authors review published data about pediatric obesity pharmacotherapy and discuss the risks of prescribing, to youth, obesity medications that are approved for adults. They also recommend that any obesity medications for adolescents be prescribed only by well-trained experts in an interdisciplinary team environment with conscientious monitoring and advocate for more research resources for pharmacological intervention trials in youth.
Pediatric obesity is linked to many poor health outcomes both in youth and adulthood, including diabetes, sleep apnea, liver disease, high blood pressure, muscle and bone problems, heart disease, and mental health problems. Obesity during adolescence can even predict how likely an individual is to die from diabetes in his or her sixties. Common treatments for obesity in adolescents include lifestyle interventions and weight reduction surgeries, but, according to the authors, medications for weight loss remain relatively underutilized.
![Mantra to Prevent Childhood Obesity – Vigorous Physical Activity]( "Mantra to Prevent Childhood Obesity – Vigorous Physical Activity")
Being physically very active is the mantra to prevent pediatric obesity rather than concentrating efforts at restricting energy consumption.
Pediatric obesity is an emerging field, and there are no official guidelines to help clinicians manage patients with medications that were originally introduced in the adult population.
In Obesity, the authors provide guidance on current best practices in using obesity medications in pediatric populations and review 10 medications for this purpose. Interventions for healthy eating and exercise should still be trialed first and continued concurrently with medication therapy later on. Adolescents with severe obesity or those who have obesity-related medical conditions would be appropriate candidates for weight loss medications, and patients and family members should actively participate in decisions to start medications, being fully aware of the potential risks and benefits. Some weight loss medications are not yet FDA-approved for pediatric use, necessitating careful discussion of potential side effects. Special considerations of side effects, such as potential impacts on growth and puberty, apply to the pediatric population.
"We hope this opinion piece on pediatric obesity pharmacotherapy will be followed by more clinical trial data, specialized pediatric obesity medicine training programs, the development of protocols and screening tools, and ultimately formal recommendations on the clinical use of medications to treat pediatric obesity," said Srivastava.
Source: Eurekalert
Mantra to Prevent Childhood Obesity – Vigorous Physical Activity
Being physically very active is the mantra to prevent pediatric obesity rather than concentrating efforts at restricting energy consumption.
Advertisement
Pediatric obesity is an emerging field, and there are no official guidelines to help clinicians manage patients with medications that were originally introduced in the adult population.
In Obesity, the authors provide guidance on current best practices in using obesity medications in pediatric populations and review 10 medications for this purpose. Interventions for healthy eating and exercise should still be trialed first and continued concurrently with medication therapy later on. Adolescents with severe obesity or those who have obesity-related medical conditions would be appropriate candidates for weight loss medications, and patients and family members should actively participate in decisions to start medications, being fully aware of the potential risks and benefits. Some weight loss medications are not yet FDA-approved for pediatric use, necessitating careful discussion of potential side effects. Special considerations of side effects, such as potential impacts on growth and puberty, apply to the pediatric population.
"We hope this opinion piece on pediatric obesity pharmacotherapy will be followed by more clinical trial data, specialized pediatric obesity medicine training programs, the development of protocols and screening tools, and ultimately formal recommendations on the clinical use of medications to treat pediatric obesity," said Srivastava.
Source: Eurekalert
Malnutrition to Obesity - The Big Leap
Obesity is the root cause of problems like diabetes, heart disease, stroke, arthritis and gall bladder disease. A serious look at our strategies is needed to tackle this fast growing epidemic.
Advertisement
 ObesityObesity is a condition where there is excess accumulation of body fat which poses a risk to the health of the individual. It can affect children and adults. | Advertisement
|
Advertisement
Recommended Reading
Latest Obesity News
Choice-based mobile food pantry program has the potential to reduce household food insecurity, improve diet quality, and tackle obesity among children.
New study attempts to identify bacterial indicator species of obesity and metabolic syndrome in adult and pediatric patients.
A new therapeutic approach using natural peptides may tackle the root cause of obesity-related conditions by preventing systemic inflammation.
By 2035, worldwide, more than 50 percent of the global population will be living with overweight and obesity, stated report.
World Obesity Day is observed on March 4. The day aims to strive towards achieving a reversal of the global obesity crisis.